Point: TheValue of Predicting Life Expectancy in Men with Clinically Localized Prostate Cancer

Authors:
Douglass B. ClaytonFrom the Department of Surgery, Division of Urology, University of Alabama at Birmingham, Birmingham, Alabama.

Search for other papers by Douglass B. Clayton in
Current site
Google Scholar
PubMedClose
 MD
and
Donald A. UrbanFrom the Department of Surgery, Division of Urology, University of Alabama at Birmingham, Birmingham, Alabama.

Search for other papers by Donald A. Urban in
Current site
Google Scholar
PubMedClose
 MD
Volume/Issue:
Volume 5: Issue 7
Online Publication Date:
Aug 2007
DOI:
https://doi.org/10.6004/jnccn.2007.0062
Full access

The prediction of life expectancy in prostate cancer screening and treatment is a controversial topic that evokes various opinions regarding its validity. The authors believe incorporating life expectancy prediction into the treatment algorithms for prostate cancer is important. Using a combination of clinical judgment and specific predictive tools, physicians can estimate the life expectancy of patients with prostate cancer. These estimates can then be used to help guide treatment discussion. Estimating life expectancy benefits older men in whom decisions regarding the best form of treatment may be difficult.

Correspondence: Donald A. Urban, MD, Department of Surgery, Division of Urology, 1105 FOT, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294. E-mail: Donald.Urban@ccc.uab.edu
  • Collapse
  • Expand
  • 1.

    Weeks JC, Cook EF, O'Day SJ et al.. Relationship of cancer patient's predictions of prognosis and their preferences of treatment. JAMA 1998;279:1709–1714.

    • Search Google Scholar
    • Export Citation
  • 2.

    Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev 2005;31:380–402.

  • 3.

    Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 1998;258:2389–2395.

    • Search Google Scholar
    • Export Citation
  • 4.

    The American Urologic Association Prostate Cancer Clinical Guidelines Panel. The management of localized prostate cancer. 1995. Available at: http://www.auanet.org/guidelines/main_reports/pca.pdf. Accessed June 24, 2007.

    • Search Google Scholar
    • Export Citation
  • 5.

    Mohler J, Babaian RJ, Boston B et al.. The NCCN Prostate Cancer Guidelines, version 2, 2007. Available at: http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf. Accessed June 24, 2007.

    • Search Google Scholar
    • Export Citation
  • 6.

    U.S. Census Bureau. U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin. Available at: http://www.census.gov/ipc/www/usinterimproj. Accessed June 24, 2007.

    • Search Google Scholar
    • Export Citation
  • 7.

    Lantz PM, Ubel PA. The use of life expectancy in cancer screening guidelines. J Gen Intern Med 2005;6:552–553.

  • 8.

    Johansson JE, Holmberg L, Johansson S et al.. Fifteen year survival in prostate cancer: a prospective, population-based study in Sweden. JAMA 1997;77:467–471.

    • Search Google Scholar
    • Export Citation
  • 9.

    Albersten PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005;293:2095–2101.

    • Search Google Scholar
    • Export Citation
  • 10.

    Hoffman RM, Barry MJ, Stanford JL et al.. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med 2006;119:418–425.

    • Search Google Scholar
    • Export Citation
  • 11.

    Johansson JE, Andren O, Andersson SO et al.. Natural history of early, localized prostate cancer. JAMA 2004;291:2713–2719.

  • 12.

    Litwin MS, Miller DC. Treating older men with prostate cancer. JAMA 2006;296:2733–2734.

  • 13.

    Wilson JR, Clarke MG, Ewings P et al.. The assessment of patient life-expectancy: how accurate are urologists and oncologists? BJU Int 2005;95:794–798.

    • Search Google Scholar
    • Export Citation
  • 14.

    Howard DH. Life expectancy and the value of early detection. J Health Econ 2005;24:891–906.

  • 15.

    Goffaux J, Friesinger GC, Lambert W et al.. Biological age—a concept whose time has come: a preliminary study. South Med J 2005;98:985–991.

  • 16.

    Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer 2000;88:653–663.

  • 17.

    Zeliadt SB, Etzioni R, Ramsey SD et al.. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care 2007;45:154–159.

    • Search Google Scholar
    • Export Citation
  • 18.

    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.

    • Search Google Scholar
    • Export Citation
  • 19.

    Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Euro J Cardiothorac Surg 2005;28:759–762.

    • Search Google Scholar
    • Export Citation
  • 20.

    Kastner C, Armitage J, Kimble A et al.. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis 2006;9:270–274.

    • Search Google Scholar
    • Export Citation
  • 21.

    Froehner M, Garbrecht B, Hakenberg OW et al.. Changing comorbidity classification patterns at radical prostatectomy during a 10-year period. Urol Oncol 2007;25:26–31.

    • Search Google Scholar
    • Export Citation
  • 22.

    Gross CP, McAvay GJ, Krumholz HM et al.. The effect of age and chronic illness of life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 2006;145:646–653.

    • Search Google Scholar
    • Export Citation
  • 23.

    Albertsen PC, Fryback DG, Storer BE et al.. The impact of comorbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156:127–132.

    • Search Google Scholar
    • Export Citation
  • 24.

    Fowler JE Jr, Terrell FL, Renfroe DL. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 1996;156:1714–1718.

    • Search Google Scholar
    • Export Citation
  • 25.

    Hall WH, Ramachandran R, Narayan S et al.. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004;4:94.

  • 26.

    Froehner M, Koch R, Litz RJ et al.. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy. Eur Urol 2005;47:190–195.

    • Search Google Scholar
    • Export Citation
  • 27.

    Extermann M, Overcash J, Lyman GH et al.. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998;16:1582–1587.

    • Search Google Scholar
    • Export Citation
  • 28.

    White HK, Cohen HJ. The older cancer patient. Med Clin North Am 2006;90:967–982.

  • 29.

    Kuo HK, Scandrett KG, Dave J, Mitchell SL. The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis. Arch Gerantol Geriatr 2004;39:245–254.

    • Search Google Scholar
    • Export Citation
  • 30.

    Mohile SG, Bylow K, Dale W et al.. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007;109:802–810.

    • Search Google Scholar
    • Export Citation
  • 31.

    Koch MO, Miller DA, Butler R et al.. Are we selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology 1998;51:197–202.

    • Search Google Scholar
    • Export Citation
  • 32.

    Krahn MD, Bremner KE, Asaria J et al.. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology 2002;60:258–263.

    • Search Google Scholar
    • Export Citation
  • 33.

    Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801–808.

    • Search Google Scholar
    • Export Citation
  • 34.

    The Health and Retirement Study. Ann Arbor: University of Michigan; 2002.

  • 35.

    Alibhai SM, Krahn MD, Cohen MM et al.. Is there age bias in the treatment of localized prostate carcinoma? Cancer 2004;100:72–81.

  • 36.

    Holmberg L, Bill-Axelson A, Helgesen F et al.. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781–789.

    • Search Google Scholar
    • Export Citation
  • 37.

    Tewari A, Johnson CC, Divine G et al.. Long-term survival probability in men with clinically localized prostate cancer: a case control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004;171:1513–1519.

    • Search Google Scholar
    • Export Citation
  • 38.

    Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006;175:99–103.

  • 39.

    Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA 2006;296:2336–2342.

  • 40.

    Wong YN, Mitra N, Hudes G et al.. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006;296:2683–2693.

    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2007 by the National Comprehensive Cancer Network
Page Numbers:
6
Article Category:
Research Article
Received:
07 Mar 2007
Accepted:
19 Mar 2007
Print Publication Date:
01 Aug 2007
Online Publication Date:
Aug 2007
Keywords:
Prostate; cancer; life expectancy
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 140 28 4
PDF Downloads 64 10 1
EPUB Downloads 0 0 0